Gilead Sciences, Inc’s recently made public that its Chief Financial Officer Dickinson Andrew D unloaded Company’s shares for reported $13.82 million on Jan 31 ’25. In the deal valued at $97.22 per share,142,180 shares were sold. As a result of this transaction, Dickinson Andrew D now holds 129,873 shares worth roughly $12.4 million.
Then, ANDREW DICKINSON bought 142,180 shares, generating $13,822,740 in total proceeds.
Before that, MERDAD V PARSEY bought 184,683 shares. Gilead Sciences, Inc shares valued at $18,098,989 were divested by the Officer at a price of $98.00 per share.
Morgan Stanley upgraded its Gilead Sciences, Inc [GILD] rating to an Overweight from a an Equal-weight in a research note published on January 10, 2025; the price target was increased to $113 from $87. Wolfe Research began covering GILD with “an Outperform” recommendation on November 15, 2024. Citigroup started covering the stock on November 14, 2024. It rated GILD as “a Buy”.
Price Performance Review of GILD
On Monday, Gilead Sciences, Inc [NASDAQ:GILD] saw its stock fall -0.58% to $95.48. Over the last five days, the stock has lost -2.95%. Gilead Sciences, Inc shares have risen nearly 3.37% since the year began. Nevertheless, the stocks have risen 28.30% over the past one year. While a 52-week high of $100.51 was reached on 02/05/25, a 52-week low of $62.07 was recorded on 01/10/25. SMA at 50 days reached $93.13, while 200 days put it at $80.60.
Levels Of Support And Resistance For GILD Stock
The 24-hour chart illustrates a support level at 94.64, which if violated will result in even more drops to 93.80. On the upside, there is a resistance level at 96.24. A further resistance level may holdings at 97.01. The Relative Strength Index (RSI) on the 14-day chart is 53.01, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.55, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 58.02%. Stochastics %K at 54.15% indicates the stock is a holding.
How much short interest is there in Gilead Sciences, Inc?
A steep rise in short interest was recorded in Gilead Sciences, Inc stocks on 2025-01-15, growing by 3.19 million shares to a total of 25.17 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 21.98 million shares. There was a rise of 12.67%, which implies that there is a positive sentiment for the stock.
